55 results
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
biphenyls, petroleum or petroleum by-products, and (b) any material, waste or substance that is defined, listed or identified as “hazardous
425
SURF
Surface Oncology, Inc.
16 Jun 23
Business combination disclosure
8:08am
) As used herein, “Hazardous Substance” means any substance listed, defined, designated, classified or regulated as a waste, pollutant or contaminant
425
gw0n56m8awmd3sh7lesj
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
k7q3l6wxo0ajf68znr
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
f7eq uqwowph
18 May 23
Other Events
5:02pm
8-K
EX-10.1
bxs 9q10mh
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am